Literature DB >> 7763589

Expansion and differentiation of human hematopoietic cells from static cultures through small-scale bioreactors.

C A Sardonini1, Y J Wu.   

Abstract

Maintenance of the progenitor cells responsible for hematopoiesis has generally been accomplished using a feeder layer of stromal cells in stationary culture. Here, we compared the expansion of the total cell and progenitor cell populations using low-density mononuclear cells (LDMCs) obtained from human bone marrow in static culture (T-flasks) and in different cell culture bioreactors designed for the scale-up of mammalian cells. Static cultures were performed without the presence of a previously established stromal cell layer. Expansion of marrow in all cases was accomplished through the use of added cytokines such as IL-3, GM-CSF, and c-kit ligand. The results for the total cell expansion in static culture ranged from 4.4- to 32-fold. The cell number increase was affected by such factors as patient to patient variability, freeze-thawing, and the combination of cytokines used. Due to widespread use and the small amount of marrow needed, static cultures were used as a basis for comparison with other expansion systems. The cell culture systems used to evaluate the scale-up of marrow cultures included suspension, microcarrier, airlift, and hollow fiber bioreactors. Using identical media, cytokines, and feed schedules, LDMCs in the suspension bioreactor expanded to a value of 1.6 compared to a normalized value of 1.0 for static cultures for the two runs investigated. Expansion results for microcarrier cultures averaged 0.75 when compared to static cultures. A cell number increase in the airlift bioreactor resulted in an expansion which was 0.70 of the control static culture. Granulocyte-macrophage and erythroid progenitor assay data were also evaluated for the suspension, microcarrier, and airlift bioreactors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 7763589     DOI: 10.1021/bp00020a600

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  7 in total

1.  Microliter-bioreactor array with buoyancy-driven stirring for human hematopoietic stem cell culture.

Authors:  Camilla Luni; Hope C Feldman; Michela Pozzobon; Paolo De Coppi; Carl D Meinhart; Nicola Elvassore
Journal:  Biomicrofluidics       Date:  2010-08-11       Impact factor: 2.800

Review 2.  Stem cell bioprocessing: fundamentals and principles.

Authors:  Mark R Placzek; I-Ming Chung; Hugo M Macedo; Siti Ismail; Teresa Mortera Blanco; Mayasari Lim; Jae Min Cha; Iliana Fauzi; Yunyi Kang; David C L Yeo; Chi Yip Joan Ma; Julia M Polak; Nicki Panoskaltsis; Athanasios Mantalaris
Journal:  J R Soc Interface       Date:  2009-03-06       Impact factor: 4.118

3.  Development of a fixed bed bioreactor for the expansion of human hematopoietic progenitor cells.

Authors:  P Meissner; B Schröder; C Herfurth; M Biselli
Journal:  Cytotechnology       Date:  1999-07       Impact factor: 2.058

4.  A cellular model for drug interactions on hematopoiesis: the use of human umbilical cord blood progenitors as a model for the study of drug-related myelosuppression of normal hematopoiesis.

Authors:  M C Léglise; P Darodes de Tailly; J L Vignot; M A Le Bot; A M Le Roux; C Riché
Journal:  Cell Biol Toxicol       Date:  1996-02       Impact factor: 6.691

5.  Ex vivo expansion of primitive hematopoietic cells for cellular therapies: An overview.

Authors:  T A McAdams; C E Sandstrom; W M Miller; J G Bender; E T Papoutsakis
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

6.  Design, characterization and application of a minibioreactor for the culture of human hematopoietic cells under controlled conditions.

Authors:  A De León; H Mayani; O T Ramírez
Journal:  Cytotechnology       Date:  1998-11       Impact factor: 2.058

7.  Blood, meat, and upscaling tissue engineering: Promises, anticipated markets, and performativity in the biomedical and agri-food sectors.

Authors:  Neil Stephens; Emma King; Catherine Lyall
Journal:  Biosocieties       Date:  2018-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.